Residue Glu83 plays a major role in negatively regulating alpha-synuclein amyloid formation
about
Nutraceuticals in Parkinson's DiseaseCountering amyloid polymorphism and drug resistance with minimal drug cocktails.Protein arginylation targets alpha synuclein, facilitates normal brain health, and prevents neurodegenerationCreation of aggregation-defective α-synuclein variants by engineering the sequence connecting β-strand-forming domains.Distinct differences in prion-like seeding and aggregation between tau protein variants provide mechanistic insights into tauopathies.Influence of EGCG on α-synuclein (αS) aggregation and identification of their possible binding mode: A computational study using molecular dynamics simulation.
P2860
Residue Glu83 plays a major role in negatively regulating alpha-synuclein amyloid formation
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Residue Glu83 plays a major ro ...... ha-synuclein amyloid formation
@ast
Residue Glu83 plays a major ro ...... ha-synuclein amyloid formation
@en
type
label
Residue Glu83 plays a major ro ...... ha-synuclein amyloid formation
@ast
Residue Glu83 plays a major ro ...... ha-synuclein amyloid formation
@en
prefLabel
Residue Glu83 plays a major ro ...... ha-synuclein amyloid formation
@ast
Residue Glu83 plays a major ro ...... ha-synuclein amyloid formation
@en
P2093
P2860
P1476
Residue Glu83 plays a major ro ...... ha-synuclein amyloid formation
@en
P2093
Benoit I Giasson
Elisa A Waxman
Kristel L Emmer
P2860
P304
P356
10.1016/J.BBRC.2009.12.079
P407
P577
2009-12-21T00:00:00Z